US FTC Asks For More Information Regarding Roche’s Illumina Takeover Bid

The U.S. Federal Trade Commission (FTC) has asked Swiss pharmaceutical company, Roche, for more information concerning the $5.7 billion hostile takeover proposal for diagnostics company Illumina Inc. Illumina, which is based in San Diego, makes systems that analyse an individual’s DNA.  It is expected that future breakthroughs will use the information to modify treatments in

Continue Reading